Name: Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27
Price: 57.59 GBP
Availability: InStock
Author: Salvatore L. Ruggiero Dmd Md Facs
ISBN: 9780323413466

portada Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27

Type

Physical Book

Publisher

Elsevier - Health Sciences Division,

Author

Salvatore L. Ruggiero Dmd Md Facs

Language

English

Format

Hardcover

ISBN13

9780323413466

Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27

Salvatore L. Ruggiero Dmd Md Facs (Author) · Elsevier - Health Sciences Division, · Hardcover

New Book

£ 57.59

£ 63.99

You save: £ 6.40

10% discount

Shipping

It will be shipped from our warehouse between Monday, July 29 and Friday, August 02.

You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Management of Medication-Related Osteonecrosis of the Jaw: An Issue of Oral and Maxillofacial Clinics of North America: Vol 27"

Editor Salvatore Ruggiero, DMD, MD and authors review the Diagnosis, Management and Prevention of Medication-related Osteonecrosis of the Jaw. Articles will include: Osteoporosis and bone modulation therapies: indications and outcomes; Antiresorptive therapies for the treatment of malignant osteolytic bone disease; Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw; Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw; Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update; Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don't know; The genetics of osteonecrosis of the jaw; Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw; Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw; The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw; Antiresorptive therapies: what they are and how do they work, and more!